Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Vogenx, Inc. announced its financial results for the third quarter of 2026 and provided a corporate update on its clinical pipeline and leadership team.
Stocks · News reference
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Vogenx, Inc. announced its financial results for the third quarter of 2026 and provided a corporate update on its clinical pipeline and leadership team.
Filed: 2026-11-06 AccNo: 0001185185-26-005214 Size: 251 KB Item 2.02: Results of Operations and Financial Condition Item 9.01: Financial Statements and Exhibits
U.S. stocks fell, but Wealthfront surged 6.6% after beating Q2 earnings and revenue estimates; Orchestra Biomed, Clover Health and AeroVironment also rose.
Flexsteel Industries Inc (FLXS) reported better-than-expected Q4 results, with shares jumping 9% in pre-market trading. Other gainers include PFSA, EJH, XOS, WETO, SGLY, VOGX, WFF, AMLX, and ENRD. Losers include SNYR, XPON, NOMA, BTAI, and YOUL.